PostEra (YC W20) Is Hiring AI Researchers for Drug Discovery

What happened

PostEra is recruiting AI researchers to advance its agentic research vertical, focusing on developing machine learning systems for drug discovery tasks such as target validation, molecular modeling, and adaptive learning from limited data.

Why it matters

This role addresses critical challenges in AI-driven drug discovery, including adapting models to new biomedical problems and improving efficiency in pharmaceutical research through advanced machine learning techniques.

• AI is becoming critical for accelerating biomedical research and drug development
• Agentic systems and in-context learning are emerging as key techniques for handling complex scientific problems
• Cross-disciplinary collaboration between AI researchers and biologists is essential for effective drug discovery
• Startups are driving innovation in applying machine learning to pharmaceutical challenges
• The field requires both theoretical machine learning expertise and domain-specific biomedical knowledge

The bigger picture

The research could improve the efficiency of drug discovery pipelines, enabling faster development of treatments for women's health, fertility, and pandemic preparedness through AI-enhanced scientific workflows.

PostEra's hiring initiative highlights the growing intersection of AI and biotechnology, focusing on developing advanced machine learning systems to address complex drug discovery challenges through innovative research approaches.

Technical details

• Agentic systems for automating biochemical process modeling
• In-context learning for molecular and tabular data
• Foundation models trained on proprietary multimodal biomedical data
• Few-shot adaptation techniques for limited labeled datasets
• Distributed training for large-scale molecular modeling tasks

FAQ